⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

September 20, 2024MedicinaOpen Access

Correlation between Overweight, Obesity, Gestational Diabetes Mellitus, Adipokines (Adipolin and Adiponectin), and Adverse Pregnancy Outcomes: A Pilot Study

Mihai Muntean Vlăduţ Săsăran Luca Sonia-Teodora Laura Mihaela Suciu Nyulas Victoria Muntean Irina Elena Claudiu Mărginean

View Full Paper

Ask AI

Bookmark

Share

Abstract

: The prevalence of overweight (OW), obesity (OB), and gestational diabetes mellitus (GDM) has been increasing worldwide in recent years. Adipolin is a new adipokine with reduced circulating levels in obesity and type 2 diabetes mellitus (T2DM).

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Muntean et al. (2024) studied this question.

synapsesocial.com/papers/68e57c2ab6db64358751b948 https://doi.org/10.3390/medicina60091544

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Serum Levels of Adipolin and Adiponectin and Their Correlation with Perinatal Outcomes in Gestational Diabetes Mellitus2024 · 8 citations
2Comparative Evaluation of Adipokine Metrics for the Diagnosis of Gestational Diabetes Mellituscase-control · 2023 · 11 citations
3Role of adiponectin in gestational diabetes mellitus: advances in mechanistic insights and early predictive potentialReview · 2026 · 1 citations
4Decreased high‐molecular‐weight adiponectin in gestational diabetes: implications for the pathophysiology of Type 2 diabetescross-sectional · 2007 · 69 citations
5Gestational diabetes mellitus–induced adipokine dysregulation and links to metabolic programming risksCohort Study · 2026 · 1 citations